Near-infrared fluorescence imaging plus indocyanine green fluorescence in patients undergoing a total thyroidectomy and central neck lymph node dissection: is it worth it?
Natalie M. Liu,Claire Graves,Michael Campbell
DOI: https://doi.org/10.21037/gs-24-181
2024-09-03
Gland Surgery
Abstract:Natalie M. Liu, Claire Graves, Michael Campbell Department of Surgery, University of California Davis Medical Center, Sacramento, CA, USA Comment on: Di Lorenzo S, Carrillo Lizarazo JL, Dionigi G, et al . Impact of near-infrared fluorescence imaging plus indocyanine green fluorescence on postoperative hypoparathyroidism rates after total thyroidectomy and central neck lymph node dissection. Br J Surg 2024;111:znae022. Keywords: Near-infrared autofluorescence (NIRAF); hypoparathyroidism; indocyanine green angiography (ICGA) Submitted May 20, 2024. Accepted for publication Aug 07, 2024. Published online Aug 22, 2024. doi: 10.21037/gs-24-181 Thyroid surgery has seen a dramatic evolution since its precarious beginnings when mortality approached 40% (1) and the procedure was banned by the French Academy of Medicine (2). The modern thyroid surgeon enjoys a practice where serious adverse events are uncommon, and most patients safely recuperate in the outpatient setting. Despite these advances, postoperative hypoparathyroidism remains a frequent and challenging complication leading to decreased patient quality of life and increased health care costs (3,4). Patients requiring a central neck dissection for thyroid cancer are at increased risk of post-operative hypoparathyroidism compared to patients undergoing thyroidectomy alone because of removal and devascularization of the parathyroids during removal of the lymph nodes (5). It is in this setting that surgeons have been searching for technology to help them identify and protect parathyroid glands during thyroid surgery. In 2013, McWade et al. published their sentinel study on the use of near-infrared autofluorescence (NIRAF) for identification of parathyroid glands during thyroid surgery (6). NIRAF technology relies on the intrinsic property of tissue to emit autofluorescence when exposed to the near-infrared spectrum of light (7,8). Parathyroid autofluorescence is notably distinct from surrounding tissues including fat, muscle, and thyroid, which allows for parathyroid tissue to be identified and protected using NIRAF technology (8). NIRAF can be coupled with indocyanine green angiography (ICGA), which is used for vascular mapping and assessing tissue perfusion. When used together, NIRAF and ICGA have shown promise as surgical adjuncts to help surgeons identify, protect, and assess the perfusion of parathyroid glands during thyroid surgery, leading to decreased rates of postoperative hypoparathyroidism (9). In the study entitled "Impact of near-infrared fluorescence imaging plus indocyanine green fluorescence on postoperative hypoparathyroidism rates after total thyroidectomy and central neck lymph node dissection", Di Lorenzo et al. compared the efficacy of NIRAF-alone, NIRAF + ICGA, and a control group using only visual identification of the parathyroids. These three groups were evaluated in their ability to protect against postoperative hypoparathyroidism in patients undergoing a total thyroidectomy with central neck dissection. In this retrospective evaluation of prospectively collected data, the authors found a significantly lower rate of transient hypoparathyroidism (less than six months) in the NIRAF + ICGA group compared with the visual identification and NIRAF-alone groups. There was no significant difference in the rates of permanent hypoparathyroidism (lasting over six months) between the three groups, but there was a trend toward improvement in both NIRAF groups, with no patients in the NIRAF + ICGA group experiencing permanent hypoparathyroidism. The authors also found a higher number of identified parathyroid glands and parathyroid gland auto-transplantation in the NIRAF-alone and NIRAF + ICGA groups compared to the control group. There were no significant differences between operative time, length of stay, and final pathology (10). NIRAF + ICGA technology represents an exciting new frontier in thyroid surgery, but like the implementation of recurrent laryngeal nerve monitoring in the 2000's, the adoption of NIRAF technology has been somewhat measured. The Di Lorenzo et al. study is part of a growing wealth of data that supports the use of NIRAF in thyroid surgery. Benmiloud et al. reported a multicenter randomized control trial using NIRAF during total thyroidectomy and found a decreased incidence of temporary hypoparathyroidism and an increased rate of parathyroid preservation during total thyroidectomy (11). Similarly, Dip et al. published a single institution randomized control trial and found that NIRAF during thyroidectomy increased intraoperative identification of parathyroid glands and decreased the incidence of postoperative hypocalcemia (12). Rossi et al. conducted a prospective randomized single institution study which showed that a significantly higher number of parathyroid glands were identified in p -Abstract Truncated-
surgery